SCHEMBL7528152

SCHEMBL7528152

CCOC(=O)c1[nH]c2c(Cl)cccc2c1-c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2 P11137 1/20 0.64
ALDH1A1 P00352 3/20 0.62
HPGD P15428 3/20 0.62
CYP1A2 P05177 1/20 0.62
XBP1 P17861 1/20 0.62
CYP2C19 P33261 1/20 0.62
CDK1 P06493 1/20 0.55
CCNB1 P14635 1/20 0.55
RPA1 P27694 1/20 0.53
MCL1 Q07820 1/20 0.53
RXFP1 Q9HBX9 1/20 0.52
CSF1R P07333 1/20 0.50
MAPT P10636 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
KDM4E B2RXH2 2/20 0.48
LMNA P02545 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
MDM2 Q00987 1/20 0.47
GAA P10253 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7530831 0.85 ALDH1A1 (0.56) MAP2ALDH1A1HPGDCYP1A2XBP1
SCHEMBL11735067 0.83 CDK1 (0.51) MAP2ALDH1A1HPGDCYP1A2XBP1
SCHEMBL4090248 0.83 CDK1 (0.57) ALDH1A1HPGDCYP1A2CYP2C19CDK1
SCHEMBL8795115 0.82 RXFP1 (0.62) ALDH1A1HPGDCYP1A2CYP2C19CDK1
SCHEMBL24896562 0.81 MAP2 (0.78) MAP2ALDH1A1HPGDRPA1MCL1
SCHEMBL2956667 0.80 ALDH1A1 (0.73) MAP2ALDH1A1HPGDCYP1A2XBP1
SCHEMBL11301354 0.80 ALDH1A1 (0.76) MAP2ALDH1A1HPGDCYP1A2XBP1
SCHEMBL18079064 0.78 RXFP1 (0.68) ALDH1A1HPGDCDK1CCNB1RXFP1
SCHEMBL7537886 0.78 MAP2 (0.73) MAP2ALDH1A1HPGDRPA1MCL1
SCHEMBL25002652 0.77 MAP2 (0.60) MAP2ALDH1A1HPGDCYP1A2XBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US disclosed
WO-2002022576-A2 3-SUBSTITUTED INDOLE CARBOHYDRAZIDES USEFUL AS CELL PROLIFERATION AND ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 2002-03-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors MKI67, FLT4, IDO1 MAP2 1547/4885ALDH1A1 98/4885HPGD 416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.